Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN)

43.80
Delayed Data
As of Feb 25
 -0.69 / -1.55%
Today’s Change
36.69
Today|||52-Week Range
67.86
-19.54%
Year-to-Date
Should Investors Buy Biohaven's Stock Now?
Feb 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close44.49
Today’s open44.88
Day’s range42.90 - 45.33
Volume784,629
Average volume (3 months)796,564
Market cap$2.6B
Data as of 6:30pm ET, 02/25/2020

Growth & Valuation

Earnings growth (last year)-22.98%
Earnings growth (this year)-60.15%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book13.25

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-1.48-3.01%
APLSApellis Pharmaceutic...-1.06-2.98%
FOLDAmicus Therapeutics ...-0.59-5.67%
----
Data as of 4:00pm ET, 02/25/2020

Financials

Next reporting dateMarch 4, 2020
EPS forecast (this quarter)-$1.87
Annual revenue (last year)$0.00
Annual profit (last year)-$240.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New Haven, Connecticut

Forecasts